CON
Company Description
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.16B | 1.90B | 1.84B | 1.72B | 1.73B |
| Net Income | 172.80M | 166.54M | 179.95M | 166.73M | 208.88M |
| EPS | 1.39 | 1.30 | 1.42 | 1.32 | 1.65 |
| Free Cash Flow | 197.06M | 210.35M | 164.98M | 228.35M | 243.85M |
| FCF / Share | 1.56 | 1.64 | 1.30 | 1.80 | 1.93 |
| Operating CF | 279.40M | 274.68M | 234.32M | 274.34M | 290.64M |
| Total Assets | 3.04B | 2.52B | 2.49B | 2.30B | N/A |
| Total Debt | 2.10B | 1.95B | 905.00M | 1.04B | N/A |
| Cash & Equiv | 79.90M | 183.25M | 31.37M | 37.66M | N/A |
| Book Value | 393.28M | 275.67M | 1.16B | 973.32M | N/A |
| Return on Equity | 0.44 | 0.60 | 0.16 | 0.17 | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 569.55M | 539.10M | 572.80M | 550.78M | 500.75M | 465.04M | 489.64M | 477.92M | 467.60M | 440.74M | 473.96M | 467.08M |
| Net Income | 50.49M | 34.69M | 48.26M | 44.56M | 38.91M | 21.51M | 44.34M | 51.74M | 48.96M | (24.48M) | 53.11M | 52.74M |
| EPS | 0.39 | 0.27 | 0.38 | 0.35 | 0.31 | 0.17 | 0.35 | 0.41 | 0.39 | -0.19 | 0.42 | 0.42 |
| Free Cash Flow | 9.93M | 180.86M | 39.42M | 63.15M | (4.03M) | 77.03M | 50.76M | 55.17M | 27.39M | 52.54M | 43.14M | 67.63M |
| FCF / Share | 0.08 | 1.43 | 0.31 | 0.50 | -0.03 | 0.60 | 0.40 | 0.44 | 0.22 | 0.42 | 0.34 | 0.53 |
| Operating CF | 21.02M | 118.69M | 60.63M | 88.38M | 11.70M | 93.71M | 65.91M | 70.43M | 44.62M | 76.18M | 58.60M | 81.85M |
| Total Assets | 2.89B | 2.86B | 2.84B | 2.84B | 2.73B | 2.70B | 2.48B | 2.36B | 2.37B | 2.33B | N/A | N/A |
| Total Debt | 2.12B | 2.10B | 2.14B | 2.18B | 2.14B | 1.95B | 1.95B | 860.98M | 907.47M | 905.00M | N/A | N/A |
| Cash & Equiv | 61.70M | 79.90M | 49.94M | 73.87M | 52.11M | 183.25M | 136.82M | 50.67M | 49.55M | 31.37M | N/A | N/A |
| Book Value | 424.71M | 393.28M | 385.49M | 342.64M | 307.12M | 275.67M | 277.78M | 1.25B | 1.20B | 1.16B | N/A | N/A |
| Return on Equity | 0.12 | 0.09 | 0.13 | 0.13 | 0.13 | 0.08 | 0.16 | 0.04 | 0.04 | -0.02 | N/A | N/A |